Nicotine occurs in tobacco smoke. It is a habit-forming substance and is prescribed by health professionals to assist smokers to quit smoking. It is rapidly absorbed from the lungs of smokers. It crosses the placenta and accumulates in the developing fetus. Nicotine induces formation of oxygen radicals and at the same time also reduces the antioxidant capacity of the lungs. Nicotine and the oxidants cause point mutations in the DNA molecule thereby changing the program that controls lung growth and maintenance of lung structure. The data available indicate that maternal nicotine exposure induces a persistent inhibition of glycolysis and a drastically increased AMP level. These metabolic changes are thought to contribute to the faster aging of the lungs of the offspring of mothers that are exposed to nicotine via the placenta and mother's milk. The lungs of these animals are more susceptible to damage as shown by the gradual deterioration of the lung parenchyma. The rapid metabolic and structural aging of the lungs of the animals exposed to nicotine via the placenta and mother's milk, and thus during phases of lung development characterized by rapid cell division, is likely due to 'programming' induced by nicotine. Since varenicline, a partial nicotine agonist, has basically the same structure as nicotine, and also binds to acetylcholine receptors in competition with nicotine (but with largely the same effect), it is not advisable to use nicotine or varenicline during gestation and lactation. Furthermore, the use of individual vitamin supplements is also not advisable because of the negative impact on the program that controls maintenance of lung structural and functional integrity and aging. A more appropriate smoking cessation program will also include a mixture of antioxidant nutrients such as in tomato juice.
Introduction
Cigarette smoke contains a number of oxidants [Pryor and Stone, 1993; Frie et al. 1991] . Consequently smokers are chronically exposed to these oxidants, including reactive oxygen species (ROS) . It has been shown that ROS induce oxidative damage to the cell's lipids, proteins and DNA [Meyer et al. 1999; Harman, 1992] , endothelial dysfunction [Madamanchi et al. 2005] . They also activate matrix-degrading enzymes [Siwik et al. 2001] .
It has been shown that stable oxidants in cigarette smoke extracts can pass through the pulmonary alveolar wall into the blood and induce systemic oxidative stress [Yamaguchi et al. 2007 ]. Therefore, women who smoke during pregnancy place their unborn child at an increased risk of poor health, including decreased lung function and possible lung diseases later in life. Although smoking during pregnancy is the leading cause of fetal morbidity and mortality and obstetric disease, many pregnant women continue to smoke. In North America between 20% and 25% of pregnant women smoke and in Spain this figure varies between 30% and 36% [Ruiz, 2006] . Although nearly 41% of smokers try to quit the habit each year, relapse is common, and only about 10% achieve and maintain abstinence. The negative effects of nicotine withdrawal account in part for the low success rate. Approved pharmacotherapies to treat nicotine dependence, such as nicotine replacement therapy (NRT) and bupropion [Siu and Tyndale, 2007] have moderate efficacy, thus additional and more effective therapies are required [Gonzales et al. 2006 ]. Varenicline appears to be such a therapy [Potts and Garwood, 2007] .
Nicotine uptake NRT is prescribed by many health professionals to assist smokers to quit the habit. Various products are on the market that smokers can use to get nicotine into their circulating system to reduce the craving for smoking. These include nicotine-containing gums, patches, lozenges and sprays [Benowitz and Dempsey, 2004] .
Nicotine is rapidly absorbed from the respiratory tract of smokers. Although it has often been assumed that pulmonary absorption of nicotine from inhaled cigarette smoke is more rapid than by other routes, the lung actually serves as a depot for nicotine and retards its entry into the arterial circulation [Brewer et al. 2004 ]. This implies that rather than that all of the nicotine inhaled in each puff is absorbed in a few seconds, it may require 3060 seconds or longer for the nicotine to be absorbed. It also readily crosses the placenta from the circulation [Matta et al. 2007] , and is absorbed via the skin of the adult and fetus [Onuki et al. 2003 ]. Nicotine levels in the breast milk of a smoker or animals that are chronically exposed to nicotine are also approximately two to three times that in plasma. This is primarily due to the partitioning of nicotine into the high-lipidcontaining [Sastry et al. 1998 ], more acidic milk [Dahlstrom et al. 1990; Luck et al. 1985] .
The typical smoker absorbs systemically about 0.3 mg nicotine/kg body weight per day [Benowitz and Jacob, 1984] . This is based on the average consumption of 17 cigarettes per day in the US. Blood or plasma nicotine concentrations sampled in the afternoon in smokers generally ranged from 10 to 50 ng/ml. The highest tissue affinity for nicotine is in the liver, kidney, spleen and lungs. The lowest affinity for nicotine is in adipose tissue. It also binds with high affinity to brain tissue [Hukkanen et al. 2005; Henningfield et al. 1993 ].
Since the pharmacokinetic characteristics of the mother are different from those of the fetus, they will respond differently to nicotine and its impact on the lungs. During pregnancy nicotine enters the fetus via the placenta. Peak nicotine levels occur between 15 and 30 minutes after it is consumed by the mother [Suzuki et al. 1974 ]. Most of the nicotine that enters the fetus returns to the maternal circulation for elimination. A certain quantity of the nicotine ends up in the amniotic fluid via the fetal urine. Consequently nicotine and cotinine accumulate in the amniotic fluid of the pregnant smoker because the nicotine eliminated by the fetus is added to the nicotine coming from the blood vessels of the amniochorionic membrane [Luck and Nau, 1984b] . The fetus is therefore exposed to higher levels of nicotine even after concentrations in maternal blood have decreased.
Although NRT is widely prescribed by health professionals to assist with quitting smoking, the questions that must be addressed are as follows. Firstly, is maternal nicotine exposure during pregnancy and lactation safe for the development of the respiratory system of the fetus and neonate? Secondly, is the use of other therapies such as bupropion or varenicline during gestation and lactation safe for the developing fetus and its respiratory system. Thirdly, are nutritional supplements safer in protecting the developing lung against the harmful effects of nicotine and possibly other interventions such as varenicline?
Nicotine and the lung Nicotine crosses the placenta and interacts with nicotine acetylcholine receptors (nAChRs) in the fetal lung. This causes changes in lung structure and function in the offspring. Consistent with this, it has previously been shown that a3, a5, and a7 nicotinic acetylcholine receptors are expressed in non-neuronal cells in monkey fetal lung, and that maternal nicotine exposure upregulates nAChR expression in fetal lung [Sekhon et al. 1999] . High affinity nAChRs are found in the membranes of normal lung cells and in lung cancer cells of all histological types Pontieri et al. 1996; Maneckjee and Minna, 1990] . These include a3, a5, a7, and b2 or b4 subunits ], of which a7 may help to modulate cell shape and affect cell-to-cell contact. It has been demonstrated that nicotine promotes cell proliferation upon its interaction with nAChRs on the surface of rodent bronchial epithelium and may contribute to dysanaptic lung growth [Wongtrakool et al. 2007 ].
It has been suggested that nicotine, which is transported across the feto-placental membranes, may be the key constituent of cigarette smoke that impairs lung development and lead to altered lung function and respiratory illness in the offspring. It has been shown that prenatal nicotine exposure downregulates the surface complexity of the parenchyma, increases collagen accumulation, upregulates surfactant protein gene expression, and induces neuro-endocrine cell hyperplasia in fetal lungs and alters pulmonary function [Sekhon et al. 2002a [Sekhon et al. , 2001 ]. In addition Klapproth et al. (1997) and Proskocil et al. (2004) have demonstrated that non-neuronal cells in lung synthesize acetylcholine (ACh), and that a cholinergic autocrine loop exists in developing lung. Thus, prenatal nicotine exposure likely affects lung development by modifying the actions of this autocrine cholinergic loop. Much remains however to be determined about the mechanism by which nicotinic signaling alters lung development.
Nicotine also activates several prosurvival signals [Minna, 2003; Cattaneo et al. 1997 ]. An example is the increase in the activity of protein kinase C (PKC) in various human and murine lung cancer cell lines when exposed to nicotine. Nicotine also elicits the activity of Raf-1 . The activation of these kinases has been shown to be responsible for the phosphorylation of Bcl-2 which antagonizes opioid-induced apoptotic signaling in lung cancer cells [Heeschen, 2001; Macklin et al. 1998; Maneckjee and Minna, 1994 ]. An increase in the phosphorylation of Akt was detected in vivo in the lungs of nicotine-treated mice and in human lung cancer cells derived from smokers. The activation of this kinase is associated with tobacco-related carcinogenesis in the lung. Although the activation of these kinases was observed in cultured cells transiently exposed to nicotine, they suggest that nicotine directly or indirectly contributes to the process of lung carcinogenesis West, 2003; Cattaneo et al. 1997; Maneckjee and Minna, 1994 ].
Furthermore, research has shown that long-term nicotine exposure results in a predisposition for the induction of genetic instability Hartwell and Kastan, 1994; Vogelstein and Kinzler, 1992] . Gene amplification is a hallmark of gene instability. Gene instability requires two critical elements, namely an inappropriate cell cycle progression and DNA damage. Long-term nicotine exposure, through the activation of Ras pathways and upregulation of cyclin D1, disrupts the G1 arrest. It also augments the production of ROS which may lead to DNA damage. This implies that exposure to nicotine via tobacco smoking or via NRT to quit smoking will make the lungs more prone to the development of cancer .
Nicotine and lung development
Metabolic development Energy metabolism. Glucose uptake and metabolism are essential for the proliferation and survival of cells, and may be enhanced in actively proliferating cell systems such as embryonic tissue. Glucose is considered to be an essential source of energy in lung tissue [O'Neill and Tierney, 1974] and is necessary for the functional development of the lung [Gilden et al. 1977; Maniscalco et al. 1978; Bourbon and Jost, 1982] . Glucose is also the main source of aglycerophosphate for surfactant synthesis in the adult lung while in fetal lung, loss of cellular glycogen from alveolar type II cells just before birth is associated with increased surfactant synthesis [Salisbury-Murphy et al. 1966] . During the alveolar phase of lung development, lung tissue is more dependent on glycogen as an energy substrate than adult lung. This is illustrated by the fact that during fasting the activity of phosphorylase of adult lung tissue decreases to conserve glycogen while the activity of phosphorylase in fetal and neonatal lung increases, thereby increasing the utilization of the lung glycogen stores. This means that the control of glycogen metabolism during the alveolar phase of lung development is different from that of adult animals [Maritz, 1988] .
Although glucose and glycogen are the primary energy substrates of adult and developing lung, fatty acids are also important. For example, during fasting, when blood fatty acid levels are elevated, fatty acids replace glucose as the primary energy substrate. Under these circumstances glucose is conserved by the lung for a-glycerophosphate synthesis and eventual surfactant formation by the type II pneumocytes [Rhoades, 1975] .
Maternal nicotine exposure during gestation and lactation result in sustained suppression of glycogenolysis and glycolysis ( Figure 1 ) in lung tissue of the rat fetus and neonate [Maritz, 1987; 1986] . The lower glycogenolytic activity is due to a lower phosphorylase activity in the lungs of the nicotine-exposed offspring [Maritz, 1986] . The ratio of inactive to active phosphorylase of lung tissue of nicotine-exposed offspring is the same as for animals that were not exposed to nicotine via the placenta and mother's milk. However, the tissue levels of both the phosphorylase fractions are lower than in the lungs of the control animals which implied that the total phosphorylase content of the lungs of the nicotine-exposed animals was lower than that of the control animals. This means that maternal nicotine exposure suppressed the synthesis of phosphorylase in the lungs of the offspring. It also implies that maternal nicotine exposure had no direct inhibitory effect on the activity of the phosphorylase in the lungs of the offspring. The lower rate of glycogen breakdown in the lungs of the animals that were exposed to nicotine via the placenta and mother's milk was rather due to a persistent decrease in the levels of the enzyme available to catalyze glycogenolysis than by an inhibition thereof. The implication is that the developing fetal and neonatal lungs of these animals are more dependent on exogenous glucose for utilization via the hexose monophosphate shunt than from glucose derived from the lung glycogen stores [Maritz, 1986] .
The uptake of exogenous glucose is carried out by glucose transporters. Glucose transporter isoforms 1 (Glut 1) and 4 (glut 4) are not present in adult lung, but are present in developing lung. Overexpression of these Glut isoforms can enhance glucose uptake into fetal lungs to support active cell proliferation, which is a common characteristic of developing lung epithelium [Iba et al. 1999] . The decrease in the flux of glucose through the glycolytic pathway of lungs of nicotine exposed rat pups is, however, not due to a compromised glucose transporter system because the total glucose turnover of the lung tissue of rats that were exposed to nicotine via the placenta and mother's milk is higher than in the lungs of those animals that were not exposed to nicotine. The higher glucose flux is actually due to a faster utilization of glucose via the hexose monophosphate shunt [Maritz, 1983] . After nicotine withdrawal the flux of glucose through the glycolytic pathway remained suppressed to the same degree than while exposed to nicotine ( Figure 1 ). The flux of glucose through the hexose monophosphate returns to normal [Maritz, 1987] .
Hexokinase (HK) catalyzes the phosphorylation of glucose before it can be metabolized by the various metabolic pathways in the cell. In rats, maternal nicotine exposure during pregnancy and lactation [Kordom et al. 2002] had no influence on the HK activity in the lungs of the offspring and thus the phosphorylation of glucose. Maternal nicotine exposure during pregnancy and lactation also had no effect on lactate dehydrogenase and pyruvate kinase activity in the lungs of the offspring, which means that the site of action of nicotine is between hexokinase and lactate dehydrogenase [Maritz, 1997b] . The decrease in the glycolytic activity, and thus the flux of glucose through this pathway, can be attributed to an inhibition of phosophofructokinase (PFK), the rate-limiting enzyme of the glycolytic pathway [Kordom et al. 2002 ]. It appears that the lower PFK activity, like the reduced phosphorylase activity, is due to interference with PFK synthesis at either the pre-or posttranslational level [Kordom, 1999] , resulting in a lower concentration of PFK and thus a slower flux of glucose via glycolysis. In a recent study it was shown that the activity of hexokinase is highest during the phase of rapid alveolarization in the developing lung. This implies that glycolysis is an important source of energy and of precursors to the developing lung during this phase of lung development that is characterized by rapid cell division [Kordom et al. 2002] . The lower PFK activity in the lungs of the nicotine-exposed animals will therefore have an adverse impact on this phase of lung development.
In addition to the reduced flux of glucose through the glycolytic pathway [Maritz, 1987] , AMP also accumulates in the lungs of the nicotine exposed rat pups. Furthermore, the AMP content of the lungs of the nicotine exposed offspring increased even after nicotine withdrawal [Maritz and Burger, 1992] . Both the persistent reduced glycolytic activity and high levels of AMP are associated with premature onset of cell senescence [Kondoh et al. 2005; Zwerschke et al. 2003 ].
This is supported by studies that showed that enhancement of glycolysis bypasses cellular senescence [Kondoh et al. 2007 ]. It is, therefore, conceivable that maternal nicotine exposure during gestation and lactation induces premature aging of the lungs of the offspring by irreversible suppression of glycolysis and the persistent high levels of AMP in the lungs of these animals ( Figure 2 ).
Xenobiotic metabolism. The respiratory system is one of the major targets for exposure to exogenous substances [Hukkanen et al. 2001] . A major source of exogenous chemicals to which the respiratory system is exposed is inhaled tobacco smoke, which contains nicotine [Russell and Feyerabend, 1978] . In addition to exposure to airborne substances, the respiratory system is also exposed to chemicals via the systemic circulation [Lee et al. 2000 ]. This is particularly true during gestation when the developing lungs are exposed to chemicals transferred from the maternal circulation, and during lactation when compounds are conveyed to the newborn via the mother's milk [Luck and Nau, 1984a] . Nicotine freely crosses the placenta [Lambers and Clarke, 1996] and is found in significant quantities in the milk of smoking mothers [Luck and Nau, 1984a] . Nicotine can therefore interact with the developing fetus and neonate in smoking mothers or mothers that are using NRT to quit smoking.
The consensus is that the cytochrome P450 (CYP) superfamily of enzymes is the principle means of the lung to metabolize these exogenous substances [Hukkanen et al. 2001] . Upon entering the lung many of the chemicals are not hazardous as such, but are frequently biotransformed by CYP enzymes into reactive intermediates. A critical factor contributing to the etiology or modification of respiratory disease is whether the lung tissue has the ability to activate or efficiently inactivate chemicals [Raunio et al. 1999 ].
Recent studies indeed showed that maternal nicotine exposure during gestation and lactation resulted in a permanent higher expression of CYP2A3 and CYP 2B1 [Gamieldien and Maritz, 2004] . It has been shown that CYP2A6 plays an important role in the formation of cancer-inducing agents such as NNK (4-(methylnitrosoamino)-(3-pyridyl)-1-butanone). It is also known that the rat ortholog CYP2A3 also induces synthesis of NNK [Carmella et al. 1997 ]. The permanent increase in expression if these CYPs may thus increase the susceptibility of the lungs of the offspring to cancer.
Structural development
Fibroblasts play a critical role in the transition from the saccular to the alveolar stage of lung development, during which there is a four-fold increase in the number of interstitial fibroblasts in the neonatal rat lung [Kauffman et al. 1974 ]. Perturbations such as hyperoxia, barotrauma and steroid therapy have been shown to interfere with Nicotine AMP ROS DNA damage Glycolysis premature aging Figure 2 . Diagram to illustrate the metabolic changes that induces premature aging in of the lung parenchyma of rats exposed to nicotine via the placenta and mother's milk [Maritz, 2008a] .
alveolar development in the rat [Massaro and Massaro, 1996] , baboon [Coalson et al. 1995] and human infants [Margraf et al. 1991] , the net result of which is a significant, often permanent, decrease in the number of alveoli.
Although the control of alveolar formation is poorly understood, a substantial body of evidence exists regarding events that coincide with alveolar septation, many of which may influence fibroblast proliferation. Lung elastic fibers are also thought to be involved in septation by providing structural support for newly emerging secondary septa. Inhibition of elastic fiber assembly has been linked to impaired septation [Kida and Thurlbeck, 1980] . In neonatal rat lung fibroblasts, elastin expression peaks during the second postnatal week; that is, during the phase of rapid alveolarization, and declines rapidly thereafter [Noguchi and Samaha, 1991] . This means that interference with lung fibroblast integrity may result in impaired lung development.
Cigarette smoke inhibits fibroblast proliferation and migration by increasing cell cycle transit time, thereby reducing the rate of alveolarization.
Consequently the surface area available for gas exchange is reduced. Cigarette smoke exposure also compromises fibroblast-induced repair responses, and may be one of the factors that contributes to the development of smokeinduced lung diseases [Nakamura et al. 1995] . Accumulation of nicotine in fibroblasts will affect glycolysis and plausibly fibroblast function too. However, in vitro studies have shown that nicotine had no effect on fibroblasts from human fetal lungs [Nakamura et al. 1995] .
In vivo studies also show that nicotine had no long-term effect on metabolism in lungs of adult animals as oppose to a permanent suppression of energy metabolism of animals that were exposed to nicotine during lung development [Maritz and Burger, 1992] . These in vitro studies were performed on cells that were not metabolically permanently compromised as opposed to the fibroblasts of lung cells of neonatal rats that had been exposed to nicotine during gestation and lactation. Therefore, since maternal nicotine exposure during gestation and lactation interferes with glucose metabolism and apoptosis in the fetal and neonatal lung, and since it may cause disruption of the interaction between lung fibroblast glucose metabolism and fibroblast function, it is plausible that it will also adversely affect the long-term maintenance of lung structure.
It is interesting to note those lung fibroblasts from patients with emphysema show a reduced proliferation rate [Holz et al. 2004 ] and premature aging [Mü ller et al. 2006] , and are characterized by slow degeneration of the lung parenchyma [Verbeken et al. 1992] .
Many agents that induce injury in the lung may do so by modifying key metabolic events for various cell populations in the lung. The type I alveolar epithelial cells for example, which cover more than 90% of the alveolar surface [Naimark, 1977] , depend on glycolysis for energy [Massaro et al. 1975] . Glycolysis also supplies the ATP required to maintain the membrane-linked Na + -K + ATPase [Paul, 1983] . The Na + -K + ATPase pump plays a vital role in maintaining cell volume, and reducing its activity by inhibition of glycolysis will therefore result in the swelling of these cells and the formation of membrane blebs [Contran et al. 1989 ]. Inhibition of glycolysis will therefore interfere with the ability of the type I cells to adapt to changes in the environment and to maintain cell volume. Since glycolysis is irreversibly suppressed in the lungs of the animals that were exposed to nicotine via the placenta and mother's milk, the activity of this pump will also be permanently lower in type I epithelial cells in the lung, and this could result in membrane blebbing and rupture of the cell membranes ( Figure 3 ). The type I epithelial cells are the most vulnerable to injury [Witchi, 1976] and the permanently reduced glycolytic activity will therefore make them even more susceptible to damage, especially when exposed to blood and airborne substances.
Alveolar type II cells have been found to be increased in the lungs of nicotine-exposed animals, which is thought to be a response to type I cell damage and death [Maritz and Thomas, 1994] . As a consequence of the proliferation of the alveolar type II cells, the type I/type II cell ratio decreased in the lungs of these animals [Maritz and Thomas, 1994] . Nicotine also stimulates surfactant synthesis in type II cells [Rehan et al. 2007; Maritz and Thomas, 1994] . Pulmonary fibroblasts are thought to be positive modulators of this process through the synthesis of keratinocyte and hepatocyte growth factors, both known to be potent mitogens for type II cells [Panos et al. 1993 ]. It appears that the negative impact of maternal nicotine exposure during gestation and lactation on the growth, development and repair processes of the lungs of the offspring is of such a nature that lung structure deteriorates faster with age than those that were not exposed to nicotine. This is illustrated by the appearance of membrane blebs (Figure 3 ), alveolar fenestrations [Maritz, 1997a] and eventually microscopic emphysema [ Figure 4 ]. The elastic tissue framework of the lungs of these animals is also compromised [Windvogel, 2007] . Exposure of fetal monkeys and rats to nicotine via the placenta during the late saccular/early alveolar phase of lung development results in an increase in the size and volume density of the primitive alveoli. As a consequence the alveolar surface area for gas exchange decrease (Collins et al. 1985; Maritz and Windvogel, 2003b) . The structural changes in the lungs of these animals actually resembles faster aging of the lungs. It is speculated that this makes the lungs more susceptible to respiratory disease.
The gradual deterioration of the lung parenchyma is clearly due to an inability of the lung epithelium and fibroblasts to maintain the structural integrity of the lungs. It is in all likelihood due to premature aging of the fibroblasts [Holz et al. 2004 ] and alveolar epithelial cells [Tsuji et al. 2003 ]. This is attributed to altered 'programming' due to the changes in the in utero environment that the developing lungs were exposed to [Maritz and Windvogel, 2005 , 2003a , 2003b .
The reason for the altered 'programming' is not clear. It is known that nicotine induces peroxidation of membrane lipids. It also reduces the antioxidant capacity of the lungs [Hussain et al. 2001; Maritz, 1993] . Since oxidants [Kalpana and Menon, 2004] and nicotine [Kleinsasser et al. 2005] can induce point mutations in DNA (Figure 2) , it is possible that the imbalance in the oxidant/antioxidant status of the developing lung, resulted in the altered 'programming' and consequently the lower glycolytic capacity of the lungs of the rats that were exposed to nicotine during gestation and lactation [Maritz, 1987] as well as the drastic increase in AMP [Maritz and Burger, 1992] . This theory is supported by the observation that maternal vitamin C supplementation during gestation and lactation prevented the lowering of the glycolytic capacity of the lungs of the offspring [Maritz, 1993] as well as the development of microscopic emphysema ( Figure 5 ). It is therefore plausible that restoration of the oxidant/antioxidant status of the mother and offspring will prevent altered 'programming' and thus premature aging of the lungs of the offspring.
Nicotine and cell signaling
Programmed cell death or apoptosis is an energydependent and genetically controlled process [White, 1996] that can be induced by a number of molecular tools [Wertz and Hanley, 1996] . Apoptosis occurs in the mesenchyme as early as day 14 of gestation in fetal rat lung, the embryonic phase of lung development, during which time branching of conducting airways is the predominant feature. The percentage of cells undergoing apoptosis increased dramatically between 18 and 22 days of gestation and remains elevated in the first day of postnatal life.
This marked increase at birth may be initiated by a number of factors such as breathing movements, hormonal changes due to labor and delivery, and/or expansion of the lungs with changes in cell shape and cellcell relationships. Most cells require attachment to extracellular matrix [Maritz, 2008b] . ME (a) (b) Figure 5 . Lung tissue of 42-day-old control rats (a) and rats exposed to vitamin C (b), via the placenta and mother's milk during gestation and lactation. ME indicates some of the enlarged alveoli characteristics of microscopic emphysema [Rayise, 2008] .
for proper growth and function. Lung epithelial cell adhesion to the extracellular matrix is mediated by cell surface receptors known as integrins [Pilewski and Albelda, 1993] which trigger a number of intracellular signaling pathways. Some of these pathways that have been shown to be involved in apoptosis include the Ras-Raf-MAP kinase pathway and the phosphatidylinositol 3-kinase pathway [Ichijo et al. 1997; Yao and Cooper, 1997] .
During the phase of rapid alveolarization between postnatal days 4 and 13 in rats, interstitial fibroblasts undergo rapid proliferation. Few alveoli are formed after this phase. Between postnatal days 13 and 21 the number of fibroblasts and type II cells decrease. This decrease in fibroblasts and type II cells occurs by means of programmed cell death or apoptosis, which peaks between postnatal days 17 and 19. Apoptosis, therefore, plays a key role in the thinning of the alveolar septa that occurs after alveolarization [Bruce et al. 1999; Schnittny et al. 1998 ].
Although apoptosis is an ongoing process in the immature lung, the rate of apoptosis after alveolarization increases owing to a decrease in the Bcl-2 mRNA and an increase in BAX mRNA in the fibroblasts on postnatal day 16. The gene products of Bcl-2 and BAX interact to form homodimers and heterodimers. Although Bcl-2 and BAX heterodimers are inactive, when BAX is in excess and BAX homodimers predominate, cells are likely to undergo apoptosis [Yang et al. 1995] . This explains the decrease in the total numbers of type II epithelial cells and fibroblasts in rats during the third postnatal week [Randall et al. 1991] .
The reduction, due to apoptosis, in the number of fibroblasts in the interstitium of the developing lung is likely to play a critical role in lung maturation, the final process of which is the transition of the alveolar wall from a double to a single capillary network layer [Bruce et al. 1999] .
Interference with the apoptotic process would be expected to have an adverse effect on lung maturation.
Cigarette smoke inhibits the proliferation and migration of human lung fibroblasts and fibroblast-mediated responses and therefore in this way also contributes to the development of emphysema [Nakamura et al. 1995] . Nicotine and cotinine inhibit apoptosis in fibroblasts [Wright et al. 1993 ], but the mechanism by which they suppress apoptosis is not known. Nicotine is known to exert its effects on many cell types by binding to nicotinic cholinergic receptors. It has been suggested that pediatric, smoking-associated pulmonary diseases, and small-cell lung carcinoma may be caused by the direct chronic stimulation of an a7-nicotinic acetylcholine receptor-initiated autocrine loop by nicotine and NNK, where NNK is formed from nicotine by nitrosation in the mammalian organism and during curing of tobacco [Fischer et al. 1990; Hecht and Hoffmann, 1990] . It is also possible that certain effects of nicotine are not receptor-mediated and may operate through unconventional nicotine receptors [Wright et al. 1993 ].
There is evidence that nicotine: (a) activates the mitogen-activated protein kinase (MAP) signaling pathway and extracellular signal-regulated kinase (ERK-2), resulting in increased expression of the Bcl-2 protein and inhibition of apoptosis, and (b) blocks the inhibition of protein kinase C (PKC) activity in lung cells. Nicotine appears to have no effect on the activities of c-jun NH-2terminal protein kinase (JNK), c-myc or p28 MAP kinases that are involved in apoptosis. While exposure to nicotine can result in the activation of two major signaling pathways (MAP-kinase and PKC) that are known to inhibit apoptosis, nicotine regulation of MAP and ERK kinase activity is not dependent on PKC. These effects of nicotine occur at concentrations that are generally found in the blood of smokers, and could lead to disruption of the critical balance between cell death and proliferation Maneckjee, 1998a, 1998b] . The inhibition of apoptosis by nicotine may contribute to the slower thinning of the alveolar septa of the lungs of rat pups that were exposed to nicotine via the placenta and mother's milk [Maritz et al. 2000] . It is also plausible that nicotine exposure of the fetus and newborn to nicotine during the phases of rapid cell division may render the lungs more susceptible to the development of cancer [Schuller et al. 2000] . No epidemiological evidence is currently available to support this however.
It has been suggested that in utero exposure of fetal pulmonary neuro-endocrine cells to nicotine or NNK may contribute to the development of pediatric lung disorders such as bronchitis and lower respiratory illnesses [Schuller et al. 2000 ], along with altered pulmonary mechanics in infants and children [Sekhon et al. 2001 ]. The nicotine-induced alterations in lung function in monkeys parallel those observed in infants of mothers who smoke during pregnancy [Sekhon et al. 2001 ]. These alterations in lung function could be induced via two mechanisms. The first is a direct effect of released 5-hydroxytryptamine (5-HT) in response to a7 nicotinic receptor stimulation on bronchial and vascular smooth muscles and fibroblast growth; the second is an indirect effect of 5-HT on pulmonary neuroendocrine cell numbers via activation of a Raf-1/MAP kinase pathway, resulting in yet more cells that can synthesize and release 5-HT. Chronic exposure to nicotine and NNK of pregnant mothers may therefore upregulate the a7 nicotinic receptor as well as components of its associated mitogenic signal transduction pathway, thereby increasing the vulnerability of infants to the development of pediatric lung disorders mentioned earlier [Sekhon et al. 2001] .
Nicotine replacement therapy Nicotine affects many neurotransmitters, but dopamine seems to be most responsible for the addictive properties of nicotine. The direct binding of nicotine to acetylcholine receptors on dopamine-containing neurons result in the overflow of dopamine in the reward centers of the brain. Several acetylcholine receptor subtypes, such as a4b2, are found in dopaminergic neurons. Unlike acetylcholine, which is rapidly degraded by acetylcholine-esterase, nicotine remains active at the a4b2 receptor sites for a prolonged period of time. While prolonged stimulation by most entities usually causes receptor downregulation, nicotine stimulation at the acetylcholine receptors causes upregulation. This upregulation desensitizes acetylcholine receptors, which results in nicotine dependence and addiction [Potts and Garwood, 2007] .
The use of NRT is widely promoted by health practitioners as a safe way to quit the smoking habit because it is suggested by some that nicotine is not harmful [Zwar et al. 2006 ]. However, several studies showed that nicotine can damage the fetal lungs, heart, and the central nervous system. Nicotine is genotoxic [Kleinsasser et al. 2005; Argentin and Cicchetti, 2004] and its toxic effect persists in the fetus after administration has stopped [Ruiz, 2006] . Studies in monkeys [Sekhon et al. 1999] have clearly showed that nicotine exposure during pregnancy increases the development of a7 nicotinic receptors in cells implicated in lung development. Pulmonary hypoplasia and other abnormalities in pulmonary and bronchial development were found in the offspring of experimental animals after exposure to nicotine during gestation by Sekhon et al. [1999] and Maritz and co-workers [2005 Maritz and co-workers [ , 2003a Maritz and co-workers [ , 2003b Maritz and co-workers [ , 1997 Maritz and co-workers [ , 1987 . It is also suggested that maternal nicotine exposure suppress lysyl oxidase activity and in this way contribute to the gradual deterioration of the lung parenchyma of the offspring. Furthermore, nicotine induces peroxidation of membrane lipids [Kalpana and Menon, 2004] which change the oxidant/antioxidant status of the lungs of the offspring. This is supported by the decrease in the vitamin C and E content of the lungs of the offspring [Balakrishnan and Menon 2007] . They also clearly show a decrease in the levels of the enzymes that catalyze the removal of antioxidants from the lung. Studies in our laboratories also show that the level of superoxide dismutase in the lungs of rats that were exposed to nicotine via the placenta and mother's milk remains significantly lower than that of rats not exposed to nicotine (unpublished data). This implies that apart from its immediate effect in the lungs of those who use NRT, nicotine intake during pregnancy and lactation will have a long-term effect on the maintenance of lung integrity and respiratory health of the offspring [Maritz, 2001] .
In addition, the a4b2 nicotinic acetylcholine receptor is upregulated by nicotine in the central nervous system (CNS) and the neurepithelial bodies (NEB) in the airways where the latter is considered to play a role as an airway chemoreceptor possibly involved in the control of breathing [Cutz and Jackson, 1999; Fu et al. 1999; Youngson et al. 1993] . Chronic nicotine exposure increases the number of pulmonary type II cells as well as NEB cells. Epidemiological studies have identified a close relationship between smoking and sudden infant death syndrome (SIDS) ]. Although the exact mechanism is not known, nicotine, a major component of tobacco smoke, may increase the vulnerability of infants to SIDS via its action on the peripheral chemoreceptors in NEB. An increase in the size and number of NEB has been reported in the lungs of SIDS victims born to smoking mothers [Cutz et al. 1996] . Studies by Holgert et al. [1995] showed that nicotine from smoking may also interfere with the postnatal resetting of the oxygen sensitivity of the peripheral arterial chemoreceptors by increasing carotid body tyrosine hydroxylas mRNA, as well as dopamine release in this period. Collectively these effects of nicotine on the peripheral arterial chemoreceptors may increase the vulnerability to hypoxic episodes and attenuate the protective chemoreflex response. These mechanisms may underlie the well-known relation between maternal smoking and SIDS. It is therefore plausible that the responses of the hyperplastic NEB to acute hypoxia may be blunted making the infants of smoking mothers [Fu et al. 2003 ], or mothers using NRT, more susceptible to NRT.
Lynx1 is co-expressed in neurons that express a4b2 and a7 nicotinic acetylcholine receptors. It is also expressed in the lung airway epithelial cells as well as type II alveolar epithelial cells ]. As such it plays a role in cellular proliferation and differentiation as well as in the control of surfactant synthesis. This implies that lynx1 may have the capacity to modulate the effects of prenatal nicotine and fetal development.
Bupropion
Bupropion is an atypical antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor, and nicotinic antagonist. It is also an effective smoking cessation aid. The mechanism of action of bupropion for smoking cessation is not well understood; however, the effect may be partly related to the ability of the drug to reduce cravings in abstinent smokers and to alleviate certain symptoms associated with nicotine withdrawal. Bupropion may also act as a noncompetitive antagonist of nicotinic receptors, suggesting that it may attenuate the rewarding effect of nicotine [Siu and Tyndale, 2007] . The side effects of bupropion treatment include insomnia, nausea, vomiting and dizziness [Boshier et al. 2000 ].
Varenicline
a4b2 nicotinic acetylcholine receptors are upregulated by chronic nicotine exposure and are implicated in nicotine addiction. Varenicline is a a4b2 nicotinic acetylcholine receptor partial agonist and is used to assist smokers to quit smoking. In vitro studies showed that varenicline, which is highly water soluble with a similar structure to nicotine, produces 68% of the response seen by binding of nicotine. In vivo studies found that the dopamine response to varenicline is 3260% of the response of nicotine. Varenicline competitively inhibits nicotine, thereby blocking the effects of nicotine at the a4b2 receptor site and so alleviate the nicotine withdrawal symptoms [Potts and Garwood, 2007] .
It appears to be safe and well tolerated by adults. It demonstrates significantly greater abstinence rates than NRT. Varenicline also shows greater reduction on measures of craving and withdrawal feelings of smoking satisfaction than NRT. This is consistent with the hypothesis that a4b2 partial agonists could be more effective as a smoking cessation aid than other therapies. It has been suggested that this receptor could stimulate release of sufficient quantities of dopamine to reduce craving and withdrawal symptoms while at the same time act as a partial antagonist for nicotine. This may reduce smoking satisfaction prior to quitting or following a slip or relapse [Gonzales et al. 2006 ].
Varenicline does have side effects such as gastrointestinal and sleep disorders. The adverse effects of varenicline are fewer than those for bupropion [Gonzales et al. 2006] . Although varenicline appears to be safe for adult use, no information is available as to its impact on fetal development when consumed during gestation and lactation. Since varenicline binding to a4b2 receptors produces largely the same responses seen by binding of nicotine, it is conceivable that it will also induce the same changes as nicotine in the 'program' that controls lung growth, development and aging in the offspring. The effects of varenicline intake during gestation and lactation on 'fetal onset of adult disease' therefore warrant thorough investigation. It is, therefore, at present not advisable for pregnant and lactating mothers to use varenicline to quit smoking.
Nutrient supplementation
Nicotine itself induces oxidant damage in various organs by increasing lipid peroxidation products and decreasing the activity of endogenous antioxidants [Sener et al. 2005 ] and the higher levels of nicotine that the fetus is exposed to than the mother implies that the fetus is also exposed to higher levels of oxidants. This can readily result in an oxidant/antioxidant imbalance which can adversely impact on cell survival and thus development of organs.
An appropriate intervention would thus be to improve the antioxidant status of the mother and of the fetus even if they keep on smoking or using NRT. The time it takes for the nicotine to reach the fetus after consumption by the mother, as well as the return of the nicotine to the mother's circulation, allows time for eliminating the nicotine so that much smaller quantities reach the fetus. Several studies showed that maternal vitamin C supplementation partially prevented the adverse effects of nicotine on lung development Maritz and van Wyk, 1997; Maritz, 1993] . However, recent studies by Rayise [2008] and Maritz [2008a Maritz [ , 2008b showed that maternal vitamin C supplementation during gestation and lactation also induces late onset of gradual parenchymal deterioration in the offspring ( Figure 5) . Although the reason for this is not known, it is suggested that it might be due to the pro-oxidant effect of vitamin C [Halliwell, 1990] . This is supported by the finding that vitamin C supplementation increases the malonaldehyde content of lungs due to peroxidation of membrane lipids and cellular injury [Baltalarli et al. 2006 ] and is consistent with the notion that oversupply of vitamin C induces a pro-oxidant effect [Rietjens et al. 2002] .
Vitamin E (a-tocopherol) is a fat-soluble antioxidant. It has been shown that vitamin E, apart from its antioxidant effect, also has pro-oxidant effects. It is suggested that increased levels of a-tocopherol such as during supplementation, upon subsequent oxidative stress, such as during smoking, result in increased levels of a-tocopherol radicals. The latter radicals can initiate lipid peroxidation. When antioxidant networks are balanced, this pro-oxidant effect of vitamin E radicals is inhibited by co-antioxidants which can reduce the radical back to vitamin E. Therefore, increasing only the levels of vitamin E, may increase the levels of vitamin E radicals which can no longer be efficiently detoxified by co-antioxidants (especially under conditions of increased oxidative stress such as smoking or NRT). This results in the possibility of prooxidant toxicity of vitamin E radicals. This biochemical rationale explains why foods containing comparably small quantities of vitamin E but also co-antioxidants provide greater health benefits than vitamin E supplements [Rietjens et al. 2002] .
The antioxidant capacity of the carotenoids such as aand b-carotene and lycopene is well known [Stahl et al. 1998; Mortensen and Skibsted, 1997 ]. However, it has been shown that aand b-carotene supplementation unexpectedly result in an increased incidence of lung cancer in smokers [Palozza et al. 1995] . It has been suggested that interaction between ROS derived from tobacco smoke may result in b-carotene oxidation and the consequent formation of toxic b-carotene metabolites [Lotan, 1999; Mayne et al. 1996] .
Apart from being antioxidants the vitamins with antioxidant function also interact to ensure effective antioxidant function. This synergistic action between the vitamins improves the antioxidant properties of the vitamins and reduces the prooxidant potential [Krinsky and Johnson, 2005] . A combination of carotenoids are, for example, more effective than single compounds [Briviba et al. 2004] . Interaction between b-carotene and a-tocopherol prevents radical initiated reactions more effectively [Fuhrman et al. 2000 ]. Vitamin C, a water-soluble vitamin, reduces the atocopheryl radical back to a-tocopherol [Krinsky and Johnson, 2005] . The strongest synergistic effects are between lycopene and other carotenoids [Stahl et al. 1998 ].
It is therefore not advisable to use these individual antioxidants in relatively high concentrations during pregnancy. On the other hand, intake of lycopene, a strong antioxidant [Moreira et al. 2005; Arab et al. 2002; Klebanov et al. 1998 ] present in tomato juice, together with other phytonutrients has no effect on lung growth and development. Moreover, it prevented all the adverse effects of maternal nicotine exposure during pregnancy and lactation on the lungs of the offspring (unpublished data). It has been shown that lycopene in tomato juice is more effective than isolated lycopene. This is attributed to the presence of other phytonutrients present in tomato juice [Rao and Argarwal, 1999] .
A new strategy to quit smoking? It is important to assist smokers to quit smoking. Several strategies are used to help smokers overcome nicotine addiction. These include NRT, varenicline and bupropion. However, smoking and nicotine is associated with induction of respiratory disease in the offspring. Nicotine intake during gestation and lactation changes the 'program' that controls lung structural maintenance and aging rendering the lungs of the offspring more susceptible to respiratory disease later in life. Ideally these strategies must not interfere with the health of the smoker or user of smoking cessation strategies. This can be achieved by combining the smoking cessation strategies with the intake of a combination of antioxidant nutrients and co-antioxidants such as in tomato juice.
It can therefore be concluded that the use of NRT, varenicline, bupropion or individual nutrients with antioxidant properties by pregnant mothers to quit smoking or to prevent the impact of oxidants is not advisable. It appears that intake of nutrients in ratios that correspond with that of fresh fruit and vegetables is a more reliable and safe way to prevent the impact of tobacco smoke on the developing fetus and neonate. Research to investigate this is essential. Fu, X.W., Nurse, C.A., Wang, Y.T. and Cutz, E. (1999) Selective modulation of membrane currents by hypoxia in intact airway chemoreceptors from neonatal rabbit. J Physiol 514: 139150. Fuhrman, B., Volkova, N., Rosenblat, M. et al. (2000) Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal 2: 491506.
